Boryung보령

Predicted impact: Low

Same Boryung building priority-rights news; Boryung is only a counterparty, and its treasury sale and ETC split were already reported.

Predicted impact: Medium

Physical split of ETC business into unlisted subsidiary; restructuring of a business worth about 1/3 of last year's revenue unknown.

Predicted impact: Low

Space life sciences partnership MOU with no disclosed financial size; routine collaboration news.

Predicted impact: Low

Space research MOU with DLR; no financial size disclosed, routine partnership news.

Predicted impact: Low

Preliminary earnings already reported; cumulative figures add little.

Predicted impact: Low

Phase 2 trial enrollment milestone; the enrollment completion was already reported in the last 14 days.

Predicted impact: Low

Phase 2 trial enrollment milestone, routine for a drug developer and no size given.